Table 5.

Adverse events in patients with HCC during TACE treatment, observed at the interventional radiology department.*

During TACE	TACE 1 (n = 85)	TACE 2 (n = 68)	TACE 3 (n = 57)	TACE 4 (n = 40)	TACE 5 (n = 25)
No complication	52 (61)	46 (68)	39 (68)	28 (70)	17 (68)
Nausea/Pain	28 (33)	22 (32)	17 (30)	12 (30)	8 (32)
Hypotension	6 (7)	0	2 (4)	2 (5)	0
Bleeding/Hematoma	4 (5)	0	0	0	0

Values are given as n (%).

*First five treatments observed. Patients could have more than one complication.

HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization.